Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Systemic Sclerosis with Blood Flow Restriction (HOME)
NCT01395732Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2011
- Primary completion
- Nov 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in systemic sclerosis (SSc), Digital ulcer, sponsored by Actelion Pharmaceuticals Ltd. Started Mar 2011; status: completed.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)Digital ulcer
Beyond the preview
Go deeper on NCT01395732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395732.